Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2011 | 1 | 3 | 158-168
Tytuł artykułu

Therapeutic effect of hesperidin with reference to biotransformation, lysosomal and mitochondrial TCA cycle enzymes against 7,12-dimethylbenz(a)anthracene-induced experimental mammary cellular carcinoma

Treść / Zawartość
Abstrakt, słowa kluczowe
Dodatkowe informacje
Warianty tytułu
Języki publikacji
The present study was aimed to investigate the therapeutic effect of hesperidin with reference to hepatic biotransformation, lysosomal and mitochondrial TCA cycle enzymes against 7,12-dimethylbenz(a)anthracene (DMBA)-induced experimental breast cancer. DMBA is a major class of chemical carcinogen present in the environment and it may increase breast cancer risk. In the present investigation, 7,12-DMBA was used as a carcinogen to induce breast cancer in rats. Hesperidin, a natural flavanoglycoside has demonstrated a wide variety of biological activities which make it a good candidate for the treatment of many oxidative stress-mediated diseases. In this study the hepatic biotransformation (Phase I, Phase II) enzymes were analyzed both in breast and liver. The lysosomal enzymes were analyzed in breast tissues and the key mitochondrial TCA cycle enzymes were analyzed in liver. The results revealed that treatment with hesperidin (30mg/kg body weight) significantly restored all the altered biochemical parameters. The ultra structural analysis of breast and histology of liver tissues inevitably supports the biochemical alterations and this was attributed due to the interaction of flavonoid hesperidin through the induction or inhibition of metabolism and also the modulating property in the lysosomal and TCA cycle compartments.
Opis fizyczny
  • 1. Coyle, Y.M., "The effect of environment on breast cancer risk", Breast Cancer Res Treat, vol. 84, 2004, p.273-288
  • 2. Boffetta, P.& Jourenkova, N.& Gustavsson, P., "Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons", Cancer Causes Control, vol. 8, 1997, p.444-472
  • 3. Shimada, T., "Xenobiotic-metabolizing enzymes involved in the activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons", Drug Metab Pharmacokinet, vol. 24, 2006, p.257-276
  • 4. International Agency for Research on Cancer, "Polynuclear aromatic compounds, part I, chemical, environmental and experimental data", IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Human., vol. Vol. 32, 1983, p.1-453
  • 5. Cignanek, M.& Neca, J.& Adamec, V.& Janosek, J.& Machala, M., "A combined chemical and bioassay analysis of traffic-emitted polycyclic aromatic hydrocarbons", Sci Total Environ, vol. 334-335, 2004, p.141-148
  • 6. Chan, H.Y.& Chen, Z.Y.& Tsang, S.C.D.& Leung, L.K., "Baicalein inhibits DMBA-DNA adduct formation by modulating CYP1A1 and CYP1B1 activities", Biomed Pharmacother, vol. 56, 2002, p.269-275
  • 7. Li, D.& Wang, M.& Dhingra, K.& Hittelman, W.N., "Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology", Cancer Res, vol. 56, 1996, p.287-293
  • 8. Pitot, H.C.& Dragon, Y.P., "The instability of tumor production to human cancer risk", McElain, J.& Slaga, T.J.& LeBoeut, R.& Pitot, H.C. (Eds.), Growth factors and tumor promotion: implication for risk assessment, Prog Clin Biol Res, vol. vol. 391, 1995, p.21-38
  • 9. Santella, R.M., "Immunological methods for detection of carcinogen-DNA damage in humans", Cancer Epidemiol Biomarkers Prev, vol. 8, 1999, p.733-739
  • 10. Gammon, M.D.& Santella, R.M.& Neugut, A.I.& Eng, S.M.& Teitalbaum, S.L.& Paykin, A. et al., "Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts", Cancer Epidemiol Biomarkers Prev, vol. 11, 2002, p.677-685
  • 11. Gammon, M.D.& Sagiv, S.K.& Eng, S.M.& Shantakumar, S.& Gaudet, M.M.& Teitalbaum, S.L. et al., "Polycyclic aromatic hydrocarbon-DNA adducts and breast cancer: a pooled analysis", Arch Environ Health, vol. 59, 2004, p.640-649
  • 12. Mruk, D.D.& Silvestrini, B.& Mo, M.& Cheng, Y.C., "Antioxidant superoxide dismutase – a review: its function, regulation in the testis, and role in male fertility", Contraception, vol. 65, 2002, p.305-311
  • 13. Scheibmeir, H.D.& Christensen, K.& Whitaker, S.H.& Jegaethesan, J.& Clancy, R.& Pierce, J.D., "A review of free radicals and antioxidants for critical care nurses", Intensive Crit Care Nurs, vol. 21, 2005, p.24-28
  • 14. Sies, H., "Biochemistry of oxidative stress", Angew Chem Int Ed Engl, vol. 25, 1986, p.1058-1071
  • 15. De Zwart, L.L.& Meerman, J.H.N.& Commandeur, J.N.M.& Vermeulen, N.P.E., "Biomarkers of free radical damage applications in experimental animals and in humans", Free Radic Biol Med, vol. 26, 1999, p.202-226
  • 16. Termini, J., "Hydroperoxide-induced DNA damage and mutations", Mutat Res, vol. 450, 2000, p.107-124
  • 17. Floyd, R.A., "The role of 8-hydroxydeoxyguanosine in carcinogenesis", Carcinogenesis, vol. 11, 1990, p.1447-1450
  • 18. Mernett, L.J., "Oxyradicals and DNA damage", Carcinogenesis, vol. 21, 2000, p.361-370
  • 19. Burcham, P.C., "Genotoxic lipid peroxidation products: their DNA damaging properties and role in formation of endogenous DNA adducts", Mutagenesis, vol. 13, 1998, p.287-305
  • 20. Stadtman, E.R., "Protein oxidation and aging", Science, vol. 257, 1992, p.1220-1224
  • 21. Klaunig, J.E.& Xu, Y.& Isenberg, J.S.& Bachowski, S.& Kolaja, K.L.& Jiang, J. et al., "The role of oxidative stress in chemical carcinogenesis", Environ Health Perspect, vol. 106, 1998, p.289-295
  • 22. Chopra, R., "The Indian scene", J Clin Oncol, vol. 19, 2001, p.106S-111S
  • 23. Cai, Y.& Luo, Q.& Sun, M.& Corke, H., "Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer", Life Sci, vol. 74, 2004, p.2157-2184
  • 24. Wattenberg, L.S., "An overview of chemoprevention: current status and future prospects", Proc Soc Exp Biol Med, vol. 216, 1997, p.133-141
  • 25. Talalay, P.& Dinkova-Kostova, A.T.& Holtzclaw, W.D., "Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis", Adv Enzyme Regul, vol. 43, 2003, p.121-134
  • 26. Garg, A.& Garg, S.& Zaneveld, L.J.D.& Single, A.K., "Chemistry and pharmacology of the Citrus flavonoids hesperidin", Phytother Res, vol. 15, 2001, p.655-669
  • 27. Deng, W.& Fang, W.I.& Wu, J., "Flavonoids functions as antioxidants: by scavenging reactive oxygen species or by chelating iron?", Radiat Phys Chem, vol. 50, 1997, p.271-276
  • 28. Suarez, J.& Herrera, M.D.& Marhuenda, E., "In vitro scavenger and antioxidant properties of hesperidin and neohesperidin dihydrochalcone", Phytomedicine, vol. 5, 1998, p.469-473
  • 29. Malterud, K.E.& Rydland, K.M., "Inhibitors of 15-lipoxygenase from orange peel", J Agri Food Chem, vol. 48, 2000, p.5576-5580
  • 30. Pradeep, K.& Park, S.H.& Ko, K.C., "Hesperidin a flavanoglycone protects against γ-irradiation induced hepatocellural damage and oxidative stress in Sprague – Dawley rats", Eur J Pharmacol, vol. 587, 2008, p.273-280
  • 31. Cassady, J.M.& Baird, W.M.& Chang, C.J., "Natural products as a source of potential cancer chemotherapeutic and chemopreventive agents", J Nat Prod, vol. 53, 1, 1990, p.23-41
  • 32. Barros, A.C.& Muranaka, E.N.& Mori, L.J.& Pelizon, C.H.& Iriya, K.& Giocondo, G. et al., "Induction of experimental mammary carcinogenesis in rats with 7,12-dimethylbenz (a) anthracene", Rev Hosp Clin Fac Med Sao Paulo, vol. 59, 5, 2004, p.257-261
  • 33. Senior, A.E.& McGowan, S.E.& Hilf, R., "A comparative study of inner membrane enzymes and transport systems in mitochondria from R3230AC mammary tumor and normal rat mammary gland", Cancer Res, vol. 35, 1975, p.2061-2067
  • 34. Kawai, Y.& Anno, H., "Mucopolysaccharide-degrading enzymes from the liver of the squid Ommastrephessloani pacificus I. hyaluronidase", Biochem Biophys Acta, vol. 242, 1971, p.428-436
  • 35. Delvin, E.& Gianetto, R., "The purification of lysosomal rat liver β-glucuronidase", Biochim Biophys Acta, vol. 220, 1970, p.93-100
  • 36. Marhun, "Rapid colorimetric assay of β-galactosidase and N-acetyl-β-D-glucuronidase in human urine", Clin Chim Acta, vol. 73, 1976, p.453-461
  • 37. Sapolsky, A.L.& Atlman, R.D.& Howell, D.S., "Cathepsin D activity in normal and osteoarthritic human cartilage", Fed Proc, vol. 32, 1973, p.1489-1493
  • 38. King, J., "The phosphohydrolysases-acid and alkaline phosphatases", Practical Clinical Enzymology, 1965, p.191–208
  • 39. Slater& Borner, W.D., "The effect of fluoride on the succine oxidase system", Biochem J, vol. 52, 1952, p.185-196
  • 40. Mehler, A.H.& Kornberg, A.& Grisolia, S.& Ochoa, S., "The enzymatic mechanism of oxidation-reductions between malate or isocitrate and pyruvate", J Biol Chem, vol. 174, 1948, p.961-977
  • 41. Reed LJ, Mukherjee BB. α-ketoglutarate dehydrogenase complex from Escherichia coli. In: Lowenstein JM, editor. Methods is enzymology. New York: Academic Press; 1969. p. 55–61.
  • 42. Boyd, M.R.& Burka, L.T., "In vivo studies on the relationship between target organ alkylation and the pulmonary toxicity of a chemically reactive metabolite of 4-ipomeanol", J Pharmacol Exp Ther, vol. 207, 1978, p.687-697
  • 43. Kamath, S.A.& Narayanan, K.A., "Interaction of Ca2+ with endoplasmic reticulum of rat liver. A standardized procedure for the isolation of rat liver microsomes", Anal Biochem, vol. 48, 1972, p.53-61
  • 44. Omura, T.& Sato, R., "The carbon monoxide binding pigment of liver microsomes", J Biol Chem, vol. 239, 1964, p.2370-2378
  • 45. Philips, A.H.& Langdon, R.G., "Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization and kinetic studies", J Biol Chem, vol. 237, 1962, p.2652-2660
  • 46. Habig, W.H.& Pabste, M.J.& Jakboy, W.B., "Glutathione-s-transferase: the first enzymatic step in mercapturic acid formation", J Biol Chem, vol. 249, 1974, p.7130-7139
  • 47. Issalbacher, K.J.& Dienstag, J.L., "Carcinomas of the liver", Fauci, A.S.& Braunwald, E.& Isselbacher, K.J. et al. (Eds.), Harrison's principles of internal medicine, 1998, 14th ed., p.579-580
  • 48. Hollman, S.& Touster, O., "Alterations in tissue levels of Urdine diphosphate-glucose dehydrogenase. Uridine diphosphate-glucuronic acid pyrophosphatase and glucuronyl transferase induced by substances influencing the production of ascorbic acid", Biochem Biophys Acta, vol. 62, 1962, p.338-352
  • 49. Halaby, R., "Lysosomal enzyme-induced cell death in MCF-7 and mammary gland cells", Breast Cancer Res, vol. 4, 2002, p.70-76
  • 50. Halaby, R.& Moreno-Boyle, A.& Pych, J., "Lysosomal enzymes induce regression of MCF-7 (a human breast carcinoma cell line) tumors growing in athymic mice", Breast Dis, vol. 19, 2004, p.225-229
  • 51. Geetha, A., "Effect of α-tocopherol on doxorubicin-induced changes in rat heart lysosomal enzymes", Ind J Exp Biol, vol. 31, 1993, p.288-290
  • 52. Halaby, R.& Moreno-Boyle, A.& Pych, J., "Lysosomal-mediated apoptosis of human breast tumors growing in athymic mice", Breast Dis, vol. 20, 2004, p.98-103
  • 53. Blicharski, J.& Lisiewicz, J.& Moszczynski, P., "Lysosomal enzymes of neutrophils in women with breast cancer", Folia Histochem Cytochem (Krakow), vol. 21, 1983, p.195-201
  • 54. Beem, E.P.& Hillebrand, M.J.& Benckhuijsen, C.& Overdijk, B., "Origin of the increased activity of beta-glucuronidase in the soluble fraction of rat mammary tumors during ovariectomy-induced regression", Cancer Res, vol. 47, 1987, p.3980-3987
  • 55. Calvo, P.& Barba, J.L.& Cabezas, J.A.& Serum, "N-acteyl β- D-glucosaminidase, beta-D-glucosidase, alpha-D-glucosidase, beta-D-fucosidase, alpha-L-fucosidase and beta-D-galactosidase levels in acute viral hepatitis, pancreatitis, myocardial infarction and breast cancer", Clin Chim Acta, vol. 119, 1982, p.15-19
  • 56. Slawson, C.& Pidala, J.& Potter, R.& Increased, "N-acteyl β-D-glucosaminidase activity in primary breast carcinomas corresponds to a decrease in N-acteyl glucosamine containing proteins", Biochem Biophys Acta, vol. 1537, 2001, p.147-157
  • 57. Devetzi, M.& Scorilas, A.& Tsiambas, E.& Sameni, M.& Fotiou, S.& Sloane, B.F. et al., "B protein levels in endometrial cancer: potential value as a tumor biomarker", Gynecol Oncol, vol. 112, 2009, p.531-536
  • 58. Roshy, S.& Sloane, B.F.& Moin, K., "Pericellular cathepsin B and malignant progression", Cancer Metastasis Rev, vol. 22, 2003, p.271-286
  • 59. Stahl, S.& Reinders, Y.& Asan, E.& Mothes, W.& Conzelmann, E.& Sickmann, A., "Protemic analysis of cathepsin B and L-deficeint mouse brain lysosomes", Biochim Biophys Acta, vol. 1774, 2007, p.1237-1246
  • 60. Stoka, V.& Turk, V.& Turk, B., "Lysosomal cysteine cathepsins: signaling pathways in apoptosis", Biol Chem, vol. 388, 2007, p.555-560
  • 61. Mylonas, I.& Makovitzky, J.& Richter, D.U.& Jeschke, U.& Briese, V.& Friese, K. et al., "expression in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis", Acta Histochem, vol. 105, 2003, p.245-252
  • 62. Rochefort, H.& Cavailles, V.& Augereau, P.& Capony, F.& Maudelonde, T.& Touitou, I. et al., "Over expression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer", J Steroid Biochem, vol. 34, 1989, p.77-182
  • 63. Cavailles, V.& Augereau, P.& Rochefort, H.& Cathepsin, "D gene is controlled by a mixed promoter and estrogens stimulate only TATA dependent transcription in breast cancer cells", Proc Natl Acad Sci U S A, vol. 90, 1993, p.203-207
  • 64. Liaudet-Coopman, E.& Beaujouin, M.& Derocq, D.& Garcia, M.& Glondu-Lassis, M.& Laurent-Matha, V. et al., "Cathepsin E: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis", Cancer Lett, vol. 237, 2006, p.167-179
  • 65. Garcia, M.& Platet, N.& Liaudet, E.& Laurent, V.& Derocq, D.& Brouillet, J.P. et al., "Biological and clinical significance of cathepsin D in breast cancer metastasis", Stem Cells, vol. 14, 1996, p.642-650
  • 66. Rochefort, H.& Garcia, M.& Glondu, M.& Laurent, V.& Liaudet, E.& Rey, J.M. et al., "Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 review", Clin Chim Acta, vol. 291, 2000, p.157-170
  • 67. Shoffner, J.M.& Wallace, D.C., "Oxidative phosphorylation diseases and mitochondrial DNA mutations: diagnosis and treatment", Annu Rev Nutr, vol. 14, 1994, p.535-568
  • 68. Padma& Setty, O.H., "Effect of administration of galactosamine hydrochloride on rat liver mitochondria", Ind J Biochem Biophy, vol. 34, 1997, p.296-301
  • 69. Sohal, R.& Dubey, A., "Mitochondria oxidative damage: hydrogen peroxide release and ageing", Free Rad Biol Med, vol. 16, 1994, p.621-626
  • 70. Modica-Napolitano JS, Sing KK. Mitochondria as targets for detection and treatment of cancer. Exp Rev Mol Med 2002, 11 April, available at
  • 71. Schatz, G., "Mitochondria: beyond oxidative phosphorylation", Biochim Biophys Acta, vol. 271, 1995, p.123-126
  • 72. Preston, T.J.& Abadi, A.& Wilson, L.& Singh, G., "Mitochondrial contributions to cancer cell physiology: potential for drug development", Adv Drug Deliv Rev, vol. 49, 2001, p.45-61
  • 73. Ortega, A.D.& Arago, M.S.& Sanchez, D.G.& Cenizo, L.S.& Willers, I.& Cuezva, J.M., "Glucose avidity of carcinomas", Cancer Lett, vol. 276, 2009, p.125-135
  • 74. Eaton, D.L.& Gallagter, E.P., "Mechanism of aflatoxin carcinogenesis", Ann Rev Pharmacol, vol. 34, 1994, p.135-172
  • 75. Zhang, Y.& Marcillat, O.& Giulivi, C.& Ernster, L.& Davies, K.J., "The oxidative inactivation of mitochondrial electron transport chain components and ATPase", J Biol Chem, vol. 265, 1990, p.16330-16336
  • 76. Vaglio, A.& Landriscina, C., "Changes in liver enzyme activity in the Teleost sparus aurata in response to cadmium intoxication", Ecotoxicol Environ Saf, vol. 43, 1999, p.111-116
  • 77. Arulkumaran, S.& Ramprasath, V.R.& Shanthi, P.& Sachdanandam, P., "Restorative effect of Kalpaamruthaa, an indigenous preparation, on oxidative damage in mammary gland mitochondrial fraction in experimental mammary carcinoma", Mol Cell Biochem, vol. 291, 2006, p.77-82
  • 78. Das& Mukherjee, S.C., "Chronic toxic effects of quinalphos on some biochemical parameters in Labeo rohita", Toxicol Lett, vol. 114, 2000, p.8-11
  • 79. Makowka, L.& Falk, R.E.& Rotstin, L.E.& Falk, J.A.& Nossal, N.& Langer, B. et al., "Reversal of experimental acute hepatic failure in rate", J Surg Res, vol. 29, 1980, p.479-487
  • 80. Sree Priya, M.& Devaki, T., "Effect of Indigofera tinctoria Linn on liver antoxidant defense system during D-galactosamine/endotoxin acute hepatitis in rodents", Ind J Exp Biol, vol. 23, 2001, p.181-184
  • 81. Dasgupta, T.& Rao, A.R.& Yadava, P.K., "Modulatory effect of Henna leaf (Lawsonia inermis) on drug metabolizing phase I and phase II enzymes, antioxidant enzymes, lipid peroxidation and chemically induced skin and forestomach papillomagenesis in mice", Mol Cell Biochem, vol. 245, 2003, p.11-22
  • 82. Herzfeld, A.& Greengard, O., "The effect of lymphoma and other neoplasms on hepatic and plasma enzymes of the host rat", Cancer Res, vol. 37, 1977, p.231-238
  • 83. Ip, C.& Lisk, D.J., "Modulation of phase I and phase II xenobiotic metabolizing enzymes by selenium-enriched garlic in rats", Nutr Cancer, vol. 28, 1997, p.184-188
  • 84. Moore, C.J.& Tricomi, W.A.& Gould, M.N., "Interspecies comparison of polycyclic aromatic hydrocarbon metabolism in human and rat mammary epithelial cells", Cancer Res, vol. 46, 1986, p.4946-4952
  • 85. Maltzman, T.H.& Christou, M.& Gould, M.N.& Jefcoate, C.R., "Effects of monoterpenoids on in vivo DMBA-DNA adducts formation and on phase I hepatic metabolizing enzymes", Carcinogenesis, vol. 12, 1991, p.2081-2087
  • 86. Nebert, D.W.& Dalton, T.D., "The role of cytochrome P450 enzymes in endogenous signaling pathways and environmental carcinogenesis", Nat Rev Cancer, vol. 6, 2006, p.947-960
  • 87. Mukherjee, S.& Koner, B.C.& Ray, S.& Ray, A., "Environmental contaminants in pathogenesis of breast cancer", Ind J Exp Biol, vol. 44, 2006, p.597-617
  • 88. Sing, M.S.& Michael, M., "Role of Xenobiotic metabolic enzymes in cancer epidemiology", Verma, M. (Eds.), Methods of molecular biology, cancer epidemiology, vol. vol. 472, 2009, p.243-264
  • 89. Moon, Y.J.& Wang, X.& Morris, M.E., "Dietary flavonoids: effects on xenobiotic and carcinogen metabolism", Toxicol In Vitro, vol. 20, 2006, p.187-210
  • 90. Ramji, S.& Lee, C.& Inaba, T.& Patterson, A.V.& Riddick, D.S., "Human NADPH-cytochrome P450 reductase over expression does not enhance the aerobic cytotoxicity of doxorubicin in human breast cancer cell lines", Cancer Res, vol. 63, 2003, p.6914-6919
  • 91. Windmill, K.F.& McKinnon, R.A.& Zhu, X.& Gaedigk, A.& Grant, D.M.& McManus, M.E., "The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies", Mutat Res, vol. 376, 1–2, 1997, p.153-160
  • 92. Hecht, S.S., "Biochemistry, biology and carcinogenicities of tobacco specific N-Nitrosamines", Chem Res Toxicol, vol. 11, 6, 1998, p.560-603
  • 93. Om Ali, Y.& Khawaga, E.& Tarwk, A.& Mohammed, S.& Elshal, F., "Protective role of Eygptian propolis against tumor in mice", Clin Chim Acta, vol. 338, 2003, p.11-16
  • 94. Mathivadhani, P.& Shanthi, P.& Sachdanandam, P., "Effect of Semecarpus anacardium Linn. nut extract on mammary and hepatic expression of xenobiotic enzymes in DMBA-induced mammary carcinoma", Environ Toxicol Pharmacol, vol. 23, 2007, p.328-334
  • 95. Timbrell, J.A., "Principles of biochemical toxicology", 1991, 2nd ed.
  • 96. Kloepper-Sams, P.J.& Stegeman, J.J., "Effects of temperature acclimation on the expression of hepatic cytochrome P450 1A RNA and protein in the fish Fundules heteroclitus", Arch Biochem Biophys, vol. 299, 1992, p.38-46
  • 97. Cajelli, E.& Ferraris, A.& Brambilla, G., "Mutagenecity of 4-hydroxynoneal in V79 Chinese hamster cells", Mutat Res, vol. 190, 1987, p.169-171
  • 98. Commandeur, J.N.M.& Stijntjes, C.J.& Vermeulen, N.P.E., "Enzymes and transport systems involved in the formation and disposition of glutathione-S-conjugates. Role in bioactivation and detoxication mechanism of xenobiotics", Pharmacol Rev, vol. 47, 1995, p.271-283
  • 99. George, S.G., "Enzymology and molecular biochemistry of phase II xenobiotic conjugating in fish", Malish, D.C.& Osternder, G.K. (Eds.), Aquatic toxicology: molecular biochemical and cellular perspective, 1994, p.37-85
  • 100. Varanasi, U.& Stein, J.E.& Nishimento, M.& Reichert, W.L.& Collier, T.K., "Chemical carcinogenesis in fish: uptake, activation and detoxification of organic xenobiotics", Environ Health Perspect, vol. 71, 1987, p.155-170
  • 101. Wattenberg, L.W., "Chemoprevention of cancer by naturally occurring and synthetic compounds", Wattenberg, L.W.& Lipkin, M.& Boone, C.W.& Kellof, G.J. (Eds.), Cancer chemoprevention, 1985, p.19-39
  • 102. Sheweita, S.A.& Tilmisany, A.K., "Cancer and phase II drug metabolizing enzymes", Curr Drug Metabol, vol. 4, 2003, p.45-58
  • 103. Fiander, H.& Schneider, H., "Dietary orthophenols that induce glutathione S-transferase and increase the resistance of cells to hydrogen peroxide are potential cancer chemo preventives that act by two mechanisms: the alleviation of oxidative stress and the detoxification of mutageneic xenobiotics", Cancer Lett, vol. 156, 2000, p.117-124
  • 104. El-Rays, B.F.& Ali, S.& Heilbrun, L.K.& Lababidi, S.& Bouwman, D.& Visscher, D. et al., "Cytochrome P450 and glutathione transferase expression in human breast cancer", Clin Cancer Res, vol. 9, 5, 2003, p.1705-1709
  • 105. Michael, M.& Doherty, M.M., "Tumoral drug metabolism: overview and its implications for cancer therapy", J Clin Oncol, vol. 23, 2005, p.205-229
  • 106. Jensson, H.& Eriksson, L.C.& Mannervik, B., "Selective expression of glutathione transferase isoenzymes in chemically induced preneoplastic rat hepatocyte nodules", FEBS Lett, vol. 187, 1995, p.115-120
  • 107. Sato, K.& Satoh, K.& Hatayama, I.& Tsuchida, S.& Soma, Y.& Shiratori, Y. et al., "Placental gluthione-S-transferase as a marker for neoplastic tissues", Mantle, T.J.& Pickett, C.B.& Hayes, J.D. (Eds.), Glutathione-S-tranferase and carcinogenesis, 1987, p.127-137
  • 108. Bishayee, A.& Oinam, S.& Basu, M.& Chatterjee, M., "Vanadium chemoprevention of 7,12-Dimethylbenz(a)anthracene-induced rat mammary carcinogenesis: probable involvement of representative hepatic phase I and II xenobiotic metabolizing enzymes", Breast Cancer Res Treat, vol. 63, 2000, p.133-145
  • 109. Kleiner, H.E.& Xia, X.& Sonoda, J.& Zhang, J.& Pontius, E.& Abey, J. et al., "Effects of naturally occurring coumarins on hepatic drug-metabolizing enzymes in mice", Toxicol Appl Pharmacol, vol. 232, 2008, p.337-350
  • 110. Wang, A.S.& Ramanathan, B.& Chien, Y.H.& Goparaju, C.M.& Jan, K.Y., "Comet assay with nuclear extract inhibition", Anal Biochem, vol. 337, 1, 2005, p.70-75
  • 111. Vrhovac VG, Gajski G, Trosic I, Pavicic I. Evaluation of basal DNA damage and oxidative stress in wistar rat leukocytes after exposure to microwave radiation. Toxicol 2009; doi:10.1016/j.tox.2009.02.008.
  • 112. Padmavathi, R.& Senthilnathan, P.& Sakthisekaran, D., "Therapeutic effect of propolis and paclitaxel on hepatic phases I and II enzymes and marker enzymes in dimethlybenz (a) anthracene induced breast cancer in female rats", Comp Biochem Physiol Toxicol Pharmacol, vol. 143, 2006, p.349-354
  • 113. Elegbede, J.A.& Maltzman, T.H.& Elson, C.E.& Gould, M.N., "Effects of anticarcinogenic monoterpenes on phase II hepatic metabolizing enzymes", Carcinogenesis, vol. 14, 1993, p.1221-1223
  • 114. Mackenzie, P.I.& Owens, I.S.& Burchell, B.& Bock, K.W.& Bairoch, A.& Belanger, A. et al., "The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence", Pharmacogenetics, vol. 7, 1997, p.255-269
  • 115. Mulder, G.J.& Coughty, M.W.H.& Burchell, B., "Glucuronidation", Mulder, G.J. (Eds.), Conjugation reactions in drug metabolism; an intergrated approach, 1990, p.51-105
  • 116. Letelier, M.E.& Pimentel, A.& Pino, P.& Lepe, A.M.& Faundez, M.& Aracena, P. et al., "Microsomal UDP-glucuronyltransferase in rat liver: oxidative activation", Basic Clin Pharmacol Toxicol, vol. 96, 2005, p.480-486
  • 117. Li, D.& Wang, M.& Firozi, P.F.& Chang, P.& Znang, W.& Baer-Dubowsha, W. et al., "Characterization of major aromatic DNA adducts detected in human breast tissues", Environ Mol Mutagen, vol. 39, 2–3, 2002, p.193-200
  • 118. Matsui, A.& Ikeda, T.& Enomoto, K.& Nakashima, H.& Omae, K.& Watanable, M. et al., "Increased formation of oxidative DNA damage, 8-hydroxy-2-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes", Cancer Lett, vol. 151, 1, 2000, p.87-95
  • 119. Steinkellner, H.& Rabot, S.& Freywald, C.& Nobis, E.& Scharf, G.& Chabicovsky, M. et al., "Effects of cruciferous vegetables and their constituents on drug metabolizing enzymes involved in the bioactivation of DNA-reactive dietary carcinogens", Mutat Res, vol. 480-481, 2001, p.285-297
  • 120. Galati, E.M.& Monforte, M.T.& Kirjavainen, S.& Foretieri, A.M.& Tripodo, M.M., "Biological effects of hesperidin- a citrus flavonoid. Part 1. Anti-inflammatory and analgesic activity", Farmaco, vol. 49, 1994, p.709-712
  • 121. Galati, G.& O’Brien, P.J., "Potential toxicity of flavonoids and other dietary phenoics: significance for their chemopreventive and anticancer properties", Free Rad Biol Med, vol. 37, 3, 2004, p.287-303
  • 122. Doostdar, H.& Burke, M.D.& Mayer, R.T., "Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1", Toxicol, vol. 144, 2000, p.31-38
  • 123. Etcheverry, S.B.& Ferrer, E.G.& Naso, L.& Rivadeneira, J.& Salinas, V.& Williams, P.A.M., "Antioxidant effects of the VO (IV) hesperidin complex and its role in cancer chemoprevention", J Biol Inorg Chem, vol. 13, 2008, p.435-447
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.